Zhen Huang
Directeur/Membre du Conseil chez WALVAX BIOTECHNOLOGY CO., LTD.
Fortune : 63 M $ au 30/04/2024
Postes actifs de Zhen Huang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| WALVAX BIOTECHNOLOGY CO., LTD. | Directeur/Membre du Conseil | 22/08/2019 | - |
| Corporate Officer/Principal | 01/01/2003 | 22/08/2019 | |
| Yuxi Walvax Biotechnology Co., Ltd. | President | - | - |
Shanghai Zerun Biotechnology Co., Ltd.
 Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Zhen Huang
Statistiques
Internationale
| Chine | 4 |
Opérationnelle
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| President | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| WALVAX BIOTECHNOLOGY CO., LTD. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Yuxi Walvax Biotechnology Co., Ltd. | |
Shanghai Zerun Biotechnology Co., Ltd.
Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China. | Health Technology |
- Bourse
- Insiders
- Zhen Huang
- Expérience
